Conferences Archive

Register
Overview
Day 1
Day 2
Hotel & Travel
Posters
PDF Download
Sponsor & Exhibits
Press Pass
Request Brochure

Gregory Weiss, professor of chemistry, molecular biology, and biochemistry, at University of California, Irvine, talks about a new paradigm in translational research.

Greg will be giving the opening keynote remarks at "Translational Approach to Cancer Therapeutics." He briefly describes what his focus is at this prominent event, and why we are at the start of such an exciting era in translational research. Watch and learn.

You can check out the interview in its entirety, free, on-demand here. Or take a look at the highlights and summary above.

Register by April 1 and Save up to $200!

This conference will bring together academic and industry scientists with clinicians in cancer research to highlight innovation in developing and advancing cancer therapeutics through translational approaches. The program will span all the way from basic research to the clinic and demonstrate methods that enable improved results. There will be ample discussion around moving novel compounds through discovery to clinical development and strategies for ensuring greater success in patients.

Topics Include:

Mechanism Guided Drug Discovery
New Approaches for Treating Cancer
Linking Diagnostics to Therapy
Deciphering the Link between Viruses and Cancer
Breast Cancer Translation

James Doroshow

James H. Doroshow, M.D., Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute

Richard Silverman

Richard B. Silverman, Ph.D., Professor, Chemistry, Weinberg College of Arts & Sciences, Northwestern University

Samir Khleif

Samir N. Khleif, M.D., Head, Cancer Vaccine Section Investigator, National Cancer Institute

Hung Y. Fan, Ph.D., Professor, Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine

Wayne W. Grody, M.D., Ph.D., Professor, Divisions of Medical Genetics and Molecular Pathology, Departments of Pathology & Laboratory Medicine, Pediatrics, and Human Genetics, UCLA School of Medicine

Brandon W. Higgs, Ph.D., Translational Sciences, MedImmune

Michael Liebman, Ph.D., Managing Director, Strategic Medicine, Inc.

Frank L. Meyskens, Jr., M.D., Director, Chao Family Cancer Center, University of California, Irvine

Boris Nikolic, M.D., Scientific Advisor, Bill & Melinda Gates Foundation

Gregory A. Weiss, Ph.D., Professor, Departments of Chemistry, Molecular Biology & Biochemistry, University of California, Irvine

Future Bio-Medical Series